1,180
Views
9
CrossRef citations to date
0
Altmetric
Review Article

A review on cardiovascular effects of newer hypoglycaemic medications

, , &
Pages 603-612 | Received 02 Apr 2017, Accepted 23 May 2017, Published online: 09 Jun 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Yunxiang Ma, Junkai Wang, Changhua Wang, Qiong Zhang, Yannan Xu, Huajin Liu, Xia Xiang & Jiangwei Ma. (2019) DPP-4 inhibitor anagliptin protects against hypoxia-induced cytotoxicity in cardiac H9C2 cells. Artificial Cells, Nanomedicine, and Biotechnology 47:1, pages 3823-3831.
Read now

Articles from other publishers (8)

Lauren D. Breite, Mackenzie Steck, Brandon Tate Cutshall, Samarth P. Shah & Brandon E. Cave. (2021) Changing Fields-Diabetes Medications Invading the Cardiovascular Space. Current Problems in Cardiology 46:3, pages 100736.
Crossref
Hongzhong Ma, Juan Du, Xiaoli Feng, Yingjun Zhang, Haihuan Wang, Suchun Ding, Aijie Huang & Jiahai Ma. (2020) Rosiglitazone alleviates myocardial apoptosis in rats with acute myocardial infarction via inhibiting TLR4/NF‑κB signaling pathway. Experimental and Therapeutic Medicine.
Crossref
Rajaa Almourani, Bhavana Chinnakotla, Richa Patel, L. Romayne Kurukulasuriya & James Sowers. (2019) Diabetes and Cardiovascular Disease: an Update. Current Diabetes Reports 19:12.
Crossref
Vargas-Uricoechea Hernando & Frias Juan Pablo. (2019) Efficacy and safety of the second generation basal insulin analogs in type 2 diabetes mellitus: A critical appraisal. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 13:3, pages 2126-2141.
Crossref
Hernando Vargas-Uricoechea & Juan Pablo Frias. (2019) Efficacy and safety of the second generation basal insulin analogs in type 2 diabetes mellitus: A critical appraisal. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 13:3, pages 1975-1989.
Crossref
Francisco Arrieta, Pedro Iglesias, Juan Pedro-Botet, Antonio Becerra, Emilio Ortega, Juan Carlos Obaya, Andreu Nubiola, Gonzalo Fernando Maldonado, Maria del Mar Campos, Romina Petrecca, José Luis Pardo, Víctor Sánchez-Margalet, José Juan Alemán, Jorge Navarro, Santiago Duran, Francisco Javier Tébar, Manuel Aguilar & Fernando Escobar. (2018) Diabetes mellitus y riesgo cardiovascular. Actualización de las recomendaciones del Grupo de Trabajo de Diabetes y Riesgo Cardiovascular de la Sociedad Española de Diabetes (SED, 2018). Clínica e Investigación en Arteriosclerosis 30:3, pages 137-153.
Crossref
Francisco Arrieta, Pedro Iglesias, Juan Pedro-Botet, Antonio Becerra, Emilio Ortega, Juan Carlos Obaya, Andreu Nubiola, Gonzalo Fernando Maldonado, Maria del Mar Campos, Romina Petrecca, José Luis Pardo, Víctor Sánchez-Margalet, José Juan Alemán, Jorge Navarro, Santiago Duran, Francisco Javier Tébar, Manuel Aguilar & Fernando Escobar. (2018) Diabetes mellitus and cardiovascular risk: Update of the recommendations of the Diabetes and Cardiovascular Disease working group of the Spanish Diabetes Society (SED, 2018). Clínica e Investigación en Arteriosclerosis (English Edition) 30:3, pages 137-153.
Crossref
Darshan Khangura, L Romayne Kurukulasuriya, Adam Whaley-Connell & James R Sowers. (2018) Diabetes and Hypertension: Clinical Update. American Journal of Hypertension 31:5, pages 515-521.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.